iiinova — where your digital self keeps evolving

Jay Lusk, MD, MBA @jayblusk.bsky.social · 24/05/2025

Proud to share my latest paper in @bmj.com www.bmj.com/content/389/.... Takeaways: Dementia incidence ⬇️, prevalence ⬆️, and dementia is unequally distributed. In an opinion article, I argue we need to redouble our efforts to manage multimorbidity across the life course: www.bmj.com/content/389/...

bmj.com

Incidence and prevalence of dementia among US Medicare beneficiaries, 2015-21: population based study

Objective To determine the incidence and prevalence of dementia in a nationally representative cohort of US Medicare beneficiaries, stratified by important subgroups. Design Population based study. ...

063

Reposted by Jay Lusk, MD, MBA

Parham Eshtehardi MD @cardioobdoc.bsky.social · 16/12/2024

Smoking cigarettes is associated with developing both subtypes of HF, independent from baseline lung function. Jackson Heart Study #CardioSky #MedSky #JAHA @robmentz.bsky.social @dranulala.bsky.social @anastasiasmihaili.bsky.social @ahajournals.bsky.social www.ahajournals.org/doi/10.1161/...

0169

Jay Lusk, MD, MBA @jayblusk.bsky.social · 02/12/2024

Really essential to have patient perspectives centered in research around DBS. Very nice paper highlighting the complexity and nuance of patient experiences in this space.

050

Jay Lusk, MD, MBA @jayblusk.bsky.social · 02/12/2024

Excellent pragmatic trial out in Lancet showing that a traditional Chinese medicine did not improve ICH outcomes. Shows how important trials are for TCM/herbal interventions. Contrast with positive trial of tongxinluo published in JAMA last year. #MedSky #StrokeSky www.thelancet.com/journals/lan...

Screenshot of title page of the lancet paper reporting a trial of the traditional Chinese medicine Zhongfeng Xingnao.

1101

Jay Lusk, MD, MBA @jayblusk.bsky.social · 29/11/2024

Really interesting pragmatic, factorial trial of feedback to PCPs on antibiotic prescribing. Adds to literature from other settings (e.g. alcohol use among college students) that this type of comparison-based intervention can be powerful to drive behavior change. www.bmj.com/content/385/...

bmj.com

Mailed feedback to primary care physicians on antibiotic prescribing for patients aged 65 years and older: pragmatic, factorial randomised controlled trial

Objectives To evaluate whether providing family physicians with feedback on their antibiotic prescribing compared with that of their peers reduces antibiotic prescriptions. To also identify effects on...

020

Reposted by Jay Lusk, MD, MBA

Michael D. Green, PhD @michaeldgreen.phd · 27/11/2024

Maybe instead grants, early career investigators will need to support their work through affiliate links and corporate brand deals in our manuscripts. “Acknowledgements: We thank Peloton for supporting our work. Use the code ‘Green’ for 10% off a yearly subscription of workouts!”🧪🛟 #MedSky

2133

Reposted by Jay Lusk, MD, MBA

Michael D. Green, PhD @michaeldgreen.phd · 25/11/2024

Now out in #AHAJournals Most studies focus on the association between socioeconomic disadvantage and 30-day Heart Failure readmissions, our work focuses on the cumulative impact on patient outcomes after diagnosis. #CardioSky #MedSky #HF @ahajournals.bsky.social www.ahajournals.org/doi/abs/10.1...

Title and author list for the article. The title is "association between socioeconomic disadvantage and risks of early and recurrent admissions among patients with newly diagnosed heart failure".

1189

Reposted by Jay Lusk, MD, MBA

Tim Riffe @timriffe1.bsky.social · 25/11/2024

New paper on how to calculate a multistate death distribution! What's that, you ask? Usually, we plot a death distribution by age at death. But age at death is the sum of our time spent in different states. If we split time between being healthy or not, then the distribution is multistate (1/3)

a multistate death distribution. This plot has healthy years in x, unhealthy years in y, and x+y (descending diagonals) is age at death. We display the death distribution as filled contours. The health measure in question is ADLs, which has a high mortality penalty, so the distribution mostly hugs the lower axis. state expectancies and total life expectancy converge on a point. SHARE data, females, ADL, 2015-17.

35414

Jay Lusk, MD, MBA @jayblusk.bsky.social · 24/11/2024

State medical board records have some amazing stories. Take this one. PA applies for a license in NC, submits license documentation. States she had changed her name, provides documents. Sounds legit. Licensed approved. Turns out, SHE STOLE ANOTHER PA’s identity?! License summarily suspended.

110

Jay Lusk, MD, MBA @jayblusk.bsky.social · 23/11/2024

New Lancet paper on disparities in life expectancy since 2000. In the “ten americas”, precipitous decline in life expectancy among “America 10” (1.3 million American Indian/Alaska Native residents in the west) stands out. Urgent need for policy interventions #MedSky www.thelancet.com/journals/lan...

0179

Jay Lusk, MD, MBA @jayblusk.bsky.social · 19/11/2024

Intensive BP control stands out. We shouldn’t be exposing healthy 80 year old patients to chronic poorly controlled BP. Care required to avoid orthostatic hypotension and falls, but the consequences of undertreated HTN are dire. So much therapeutic nihilism about this… #MedSky #CardioSky #GeriSkys

1124

Jay Lusk, MD, MBA @jayblusk.bsky.social · 19/11/2024

Best thing about #AHA2024 is the chance to catch up with shared connections: “academic families.” Wonderful to see @michaeldgreen.com + Duke Undergrad Perisa Ashar. Common thread is mentor Emily O’Brien who has been instrumental to all our careers and connections with each other #CardioSky #MedSky

021

Jay Lusk, MD, MBA @jayblusk.bsky.social · 18/11/2024

Moderated an amazing presentation from @vinaykini.bsky.social #AHA2024 now published in @jaccjournals.bsky.social. Outstanding work with thoughtful causal inference methods to show no improvement in care quality after vertical integration of cardiology practices. #CardioSky #MedSky

061

Jay Lusk, MD, MBA @jayblusk.bsky.social · 18/11/2024

Primary prevention of heart failure ought to be a central focus of #preventivemedicine and chronic disease prevention. Everything we do to prevent heart failure in primary care and prevention clinics will have positive knock-on effects on other CVD and prevent multimorbidity accumulation.

031

Jay Lusk, MD, MBA @jayblusk.bsky.social · 18/11/2024

Great slate of #healthpolicy #qcor moderated posters here at #aha2024. Come join Paula Chatterjee and I at MDP12 in Zone 3 to hear some exciting work in cardiovascular health policy! #cardiosky #medsky

030

Jay Lusk, MD, MBA @jayblusk.bsky.social · 17/11/2024

Any #aha2024 #cardiosky #neurosky interested in whether INR levels predict ischemic stroke severity for patients taking DOACs? Come over to Zone 4 (4047) and take a look at our poster.

150

Jay Lusk, MD, MBA @jayblusk.bsky.social · 16/11/2024

Great presentations at #aha2024. Come to MDP Session 13 to hear the exciting work! #cardiosky

020

Jay Lusk, MD, MBA @jayblusk.bsky.social · 16/11/2024

Small, retrospective study evaluating CPAP for secondary prevention of CVD after AMI. As expected, long-term adherence to CPAP (>4 hours per night) is associated with 50% decreased risk of recurrent MACCE. I suspect impact on #htn control may drive effect. Need for larger and prospective studies.

222

Jay Lusk, MD, MBA @jayblusk.bsky.social · 16/11/2024

Incredible evidence to support more focus on control of #htn. Hyperglycemia is not the only contributor to CVD risk in T2DM. We can’t be content with SBPs in the 130s. Time to tackle therapeutic inertia in HTN treatment!

010

Jay Lusk, MD, MBA @jayblusk.bsky.social · 16/11/2024

Another incredible win for GLP-1RA/GIP Tirzepatide in SUMMIT! 38% reduction in CVD death/worsening HF and improved patient-reported outcomes. Time for policy change to get these therapies to patients with #obesity #hfpef #aha2024 #cardiosky

2153

Jay Lusk, MD, MBA @jayblusk.bsky.social · 16/11/2024

Hi everyone! I am a preventive medicine physician and clinician-scientist in clinical data science and #populationhealth. I’m excited to leverage the power of #bigdata to improve care for #chronicdisease. You can learn more about me at jaylusk.md. Hope to meet other #publichealth folks here!

jaylusk.md

Jay Lusk

1111